CENPJ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.935000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.793400E-01
Normal-vs-Stage2
4.828600E-01
Normal-vs-Stage3
2.574400E-01
Normal-vs-Stage4
9.353400E-01
Stage1-vs-Stage2
8.481200E-01
Stage1-vs-Stage3
3.986200E-01
Stage1-vs-Stage4
3.900000E-01
Stage2-vs-Stage3
1.742370E-01
Stage2-vs-Stage4
3.467400E-01
Stage3-vs-Stage4
7.376400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.997200E-01
Normal-vs-AfricanAmerican
1.432790E-01
Normal-vs-Asian
5.934200E-01
Caucasian-vs-AfricanAmerican
1.548580E-01
Caucasian-vs-Asian
9.207000E-01
AfricanAmerican-vs-Asian
1.694610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.774800E-01
Normal-vs-Female
5.388600E-01
Male-vs-Female
7.932200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.845400E-01
Normal-vs-Age(41-60Yrs)
6.202400E-01
Normal-vs-Age(61-80Yrs)
4.888600E-01
Normal-vs-Age(81-100Yrs)
4.347400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.290200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.981400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.250600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.781400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.400600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.205600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.778600E-01
Normal-vs-Daily Drinker
2.268200E-01
Normal-vs-Weekly Drinker
9.831800E-01
Normal-vs-Occasional Drinker
5.984800E-01
Normal-vs-Social Drinker
8.619200E-01
Non Drinker-vs-Daily Drinker
9.402800E-01
Non Drinker-vs-Weekly Drinker
5.258400E-02
Non Drinker-vs-Occasional Drinker
4.047600E-01
Non Drinker-vs-Social Drinker
2.949800E-02
Daily Drinker-vs-Weekly Drinker
4.960000E-02
Daily Drinker-vs-Occasional Drinker
4.346400E-01
Daily Drinker-vs-Social Drinker
6.516400E-02
Weekly Drinker-vs-Occasional Drinker
3.496400E-01
Weekly Drinker-vs-Social Drinker
7.151000E-01
Occasional Drinker-vs-Social Drinker
2.309600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.793400E-01
Normal-vs-Grade 2
9.109000E-01
Normal-vs-Grade 3
8.666200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.000820E-01
Grade 1-vs-Grade 3
5.663500E-02
Grade 1-vs-Grade 4
9.793400E-01
Grade 2-vs-Grade 3
4.091400E-01
Grade 2-vs-Grade 4
9.109000E-01
Grade 3-vs-Grade 4
8.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.028000E-01
Normal-vs-NonDiabetic
5.501400E-01
Diabetic-vs-NonDiabetic
2.455000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.318600E-01
Normal-vs-NoPancreatitis
4.472000E-01
Pancreatitis-vs-NoPancreatitis
4.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.161600E-01
Normal-vs-N1
4.140000E-01
N0-vs-N1
2.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.508000E-01
Normal-vs-TP53-NonMutant
3.900000E-01
TP53-Mutant-vs-TP53-NonMutant
2.452000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
